Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.

Pharmacist assessment needed to prevent inappropriate medications in elderly cancer patients

14 Aug 2019

Current prescribing practices in elderly patients with cancer can be optimized if clinical pharmacists will evaluate potentially inappropriate medications, suggests a recent study.

A total of 114 cancer patients (mean age, 71.78 years; 55.26 percent male) were included. Hypertension and diabetes were the most common concurrent diseases, occurring in 45 (39.47 percent) and 26 (22.81 percent) patients, respectively.

Of the patients, 94.73 percent had polypharmacy, receiving at least five medications. According to the Screening Tool of Older Person’s Prescriptions criteria, 18 patients (17.79 percent) used their medications inappropriately. Furthermore, 112 patients (98.25 percent) had medication omissions according to the Screening Tool to Alert doctors to Right Treatment criteria.

In an earlier study involving 1,329 patients in one region in southern Ireland, results showed that potentially inappropriate drug prescribing and errors of medication omission were highly prevalent among older people living in the community. [Br J Clin Pharmacol 2009;68:936-947]

Another study found an increase in the number of potentially inappropriate medications globally during hospitalization, with a statistical analysis showing that the comorbidity affected the level of inappropriate prescriptions. It further suggested for clinicians to make use of specific tools to guide them towards a more rational use of medicines and reduce probable multidrug-related complications. [Int J Clin Pharm 2016;38:462-468]

The current study assessed potentially inappropriate medication use in elderly patients with cancer at an outpatient oncology clinic from December 2014 to March 2015. Potentially inappropriate medication in this cohort was identified using the Screening Tool of Older Person's Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.